Experts discuss effective communication strategies for managing patient and caregiver expectations about treatment adverse ...

Patricia Jakel, MN, RN, AOCN, emphasized that the bond oncology nurses have with patients with cancer necessitates honest and ...

Experts discuss how to balance treatment intensity with maintaining quality of life, particularly in patients with advanced-stage disease.

Staying up to date with data from trials and information from organizations dedicated to cancer research is crucial for ...

Although participants in the study had greater rates of nonadherence postintervention, those who reported nonadherence at ...

A recent study found that toxicity is routinely minimized in phase 3 oncology trials, especially those that are not industry sponsored.

And again, it's very important that we educate the population. And when nurses are educated on the different subtypes of breast cancer, then we can also—we feel empowered. And now we can empower the ...

Panitumumab plus ipilimumab and nivolumab signaled complete or partial response in 18 patients with KRAS/NRAS/BRAF wild-type MSS mCRC at the 12-week mark. The addition of ipilimumab (Yervoy) and ...

Oncology nurses and APPs play a key role in educating patients on BREAKWATER study findings and their impact on BRAF-mutant ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Hazards of the LA wildfires necessitate awareness that first responders and those central to the fires may be at risk for ...

One of the hardest lessons learned occurred after I inadvertently failed at communication and education before transferring a ...